Article
Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from Southern Mexico.
Molecular genetics & genomic medicine - 1 Jan 2020
Santoscoy-Ascencio Guillermo, Baños-Hernández Christian Johana, Navarro-Zarza José Eduardo, Hernández-Bello Jorge, Bucala Richard, López-Quintero Andres, Valdés-Alvarado Emmanuel, Parra-Rojas Isela, Illades-Aguiar Berenice, Muñoz-Valle José Francisco
Abstract excerpt
BACKGROUND: Macrophage migration inhibitory factor (MIF) is a cytokine capable of stimulating inflammatory cytokine and matrix metalloproteinase production from macrophages and synovial fibroblasts, which leads to persistent inflammation and bone degradation, two of the major pathological processes in rheumatoid arthritis (RA). The aim of this study was to evaluate the association of MIF promoter polymorphisms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
